TAVOCTAME | Piperacillin + Tazobactam (2+0.25)G & (4+0.5)G

TAVOCTAME | Piperacillin + Tazobactam (2+0.25)G & (4+0.5)G
Product Description

The Pharmaceutical Company COOPER S.A. offers a wide range of products which includes Piperacillin Sodium+Tazobactam Sodium. It is a type of parenterals. Form: Powder for Solution for Injection. BTX1VIAL. Strength: (4+0.5)G/VIAL. Therapeutic group: Antibiotics, Combination of Penicillins. Expected to be marketed in 2018.

COOPER PHARMACEUTICALS S.A.

  • Country/Region:
    Greece
  • Founded:
    1936
  • On CPHI since:
    2017
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
CMO/CDMO
Contract Service
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Finished Formulation products Distributor/Buyer
Medical Devices
Pharmaceutical Company (generic finished products)

COOPER PHARMACEUTICALS S.A.

  • Country/Region:
    Greece
  • Founded:
    1936
  • On CPHI since:
    2017
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
CMO/CDMO
Contract Service
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Finished Formulation products Distributor/Buyer
Medical Devices
Pharmaceutical Company (generic finished products)

More Products from COOPER PHARMACEUTICALS S.A. (65)